Navigation Links
BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
Date:5/15/2009

lanoma in 2007. Prevalence of stage III and stage IV disease is 120,000 and median survival for Stage IV disease is six months.

Treatment of melanoma depends on the stage of the disease with surgical resection being effective in less severe non metastatic forms of the disease. However, survival rates for later Stage III and IV patients are poor, reflecting the lack of any efficacious drugs for metastatic disease. Current systemic therapies are not generally effective in terms of generating durable responses or in impacting survival. As a result, many patients presenting with metastatic disease are directly enrolled into a clinical trial. The vast majority of experimental therapies have failed to show more than a single digit durable response rate.

About BioVex

BioVex is a privately held biotechnology company based in Woburn, MA where it also has an operational launch grade manufacturing facility. The Company is developing a new class of potent biologics for the treatment of cancer and prevention of infectious disease.

The Company's lead cancer technology platform, OncoVEX GM-CSF is a first-in-class oncolytic, or cancer destroying virus technology. OncoVEX GM-CSF works by; replicating and spreading within solid tumors (whilst leaving healthy tissue unharmed), causing the death of cancer cells; and through stimulating the immune system to destroy un-injected metastatic deposits. Both modes of action have been clearly validated in the clinic, where multiple patients with metastatic disease progressing at enrollment have been declared disease free. BioVex believes OncoVEX GM-CSF has the potential to become a leading standard of care in the treatment of many solid tumors based on the strength of clinical data generated to date, coupled with a benign side effect profile. Previous clinical trials have enrolled patients with breast cancer, head and neck cancer, and pancreatic cancer in addition t
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready to hit ... SOCKS. Since the socks were first introduced, they have rapidly been gaining attention ... inspired four new, fun shades including: blue, lime, pink and red. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national ... season with important lessons on how to stay water safe with the help of ... Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... (NPWT) - pipeline review 2015” provides comprehensive information on the pipeline products ... report on negative pressure wound therapy (NPWT) with 22 market data tables ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... them with care and precision. There is an art and science that goes ... honor of successfully reshaping the facial features and lives of more than 2,500 ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... consulting services to the federal government, has announced they are among nine contractors ... Management Office Support Services (BMOSS) contract not to exceed $250 million. , ...
Breaking Medicine News(10 mins):Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2
... and young children treated with heart drugs get the wrong ... errors more often than older children, according to research led ... 6 in Pediatrics . While the researchers ... age of 1, they say children of all ages are ...
... ROCHESTER, Minn. -- Chemical dependency and recovery in patients ... articles and editorials in the July 2009 issue of ... timely. As the immense challenges, including potential tragedies, of ... articles offer crucial overview, direction and optimism. ...
... , BALTIMORE, July 7 DaVita Inc. (NYSE: ... services for those diagnosed with chronic kidney disease (CKD), ... award-winning, leadership development and cultural orientation program for new ... DaVita,s commitment to teammate empowerment and engagement are former ...
... DRINKiQ.com , Diageo,s cutting edge responsible drinking web ... Outstanding Health and Wellness web site by the International Academy ... runner-up in the Education Category. Now in its 15th ... professionals. The program is sanctioned by the International Academy of ...
... ... expansion efforts , ... (Vocus) July 7, 2009 -- KePRO , a leading quality improvement and care management ... responsible for executing KePRO,s sales plans in order to increase KePRO,s market share and the ...
... (NYSE: AMB ), a leading owner, operator and ... fully leased a 328,000 square foot (30,500 square meter) facility ... GmbH, a leading global medical device company. The new lease, ... 210,000 square feet (19,500 square meters), and increases their lease ...
Cached Medicine News:Health News:Wrong dose of heart meds too frequent in children 2Health News:A comprehensive review of addiction to prescription painkillers among patients and physicians 2Health News:A comprehensive review of addiction to prescription painkillers among patients and physicians 3Health News:DaVita's Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland 2Health News:Diageo's DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts 2Health News:Diageo's DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts 3Health News:KePRO Names Two New Business Development Directors 2Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 2Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 3Health News:AMB Property Corporation(R) Leases 440,000 SF in Hamburg 4
(Date:7/2/2015)... , July 2, 2015  The Commission ... agreement with ASHP, an organization that represents pharmacists ... a provider of continuing education for recertification of ... track of geriatric programs for this purpose.  ASHP ... as authorized providers for the CCGP Professional Development ...
(Date:7/2/2015)... SEOUL , South Korea, July 2, 2015 ... of a new E-CUBE Series ultrasound system. Developed to ... of clinical areas, the E-CUBE 15 EX produces superb ... outstanding clinical performance in women,s health, general imaging, and ... The latest in the renowned E-CUBE Series, ...
(Date:7/2/2015)... 2015 Research and Markets( ... "Veterinary / Animal Vaccines Market by Product, Diseases & ... their offering. The global animal vaccines market ... $5,507.3 Million in 2015, at a CAGR of 5.5% ... market growth are growing prevalence of animal diseases, increasing ...
Breaking Medicine Technology:Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2
... testing can be,used to help personalize the therapeutic ... published in the,September 1, 2007, issue of Blood, ... result represents one of the first applications of ... care., Because individuals metabolize drugs differently, varying ...
... Acura Pharmaceuticals,Inc. (OTC Bulletin Board: ACUR) (the ... Purchase Agreement (the "Agreement"), with an,investor group comprised ... Fund,VI Affiliates Fund, L.P., GCE Holdings LLC and ... the Investors purchased,23,605,551 Units ("Units") at a price ...
Cached Medicine Technology:Genetics Determine Optimal Drug Dose of Common Anticoagulant 2Genetics Determine Optimal Drug Dose of Common Anticoagulant 3Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 2Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: